Jiangsu Hengrui Medicine Co., Ltd. (SHA:600276)

Jiangsu Hengrui Medicine had revenue of 8.56B CNY in the quarter ending June 30, 2025, with 12.53% growth. This brings the company's revenue in the last twelve months to 30.15B, up 19.38% year-over-year. In the year 2024, Jiangsu Hengrui Medicine had annual revenue of 27.98B with 22.63% growth.

• Revenue (ttm): 30.15B
• Revenue Growth: +19.38%
• P/S Ratio: 14.44
• Revenue / Employee: 1.49M
• Employees: 20,238
• Market Cap: 435.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.98B	5.16B	22.63%
Dec 31, 2023	22.82B	1.54B	7.26%
Dec 31, 2022	21.28B	-4.63B	-17.87%
Dec 31, 2021	25.91B	-1.83B	-6.59%
Dec 31, 2020	27.73B	4.45B	19.09%